Literature DB >> 10430435

A SOD1 gene mutation in a patient with slowly progressing familial ALS.

S Penco1, A Schenone, D Bordo, M Bolognesi, M Abbruzzese, O Bugiani, F Ajmar, C Garrè.   

Abstract

We report a new missense mutation (Gly12Arg) [corrected] in exon 1 of the Cu/Zn superoxide dismutase (SOD1) gene in a 67-year-old patient with familial ALS (FALS). The clinical course showed an unusually slow progression. The enzymatic activity of the mutated SOD1 was 80% of normal. At the molecular level, the Gly12Arg [corrected] mutation occurs in a region outside the active site and may lead to local distortion strain in the protein structure.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10430435     DOI: 10.1212/wnl.53.2.404

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

1.  SOD1 mutations in amyotrophic lateral sclerosis. Results from a multicenter Italian study.

Authors:  Stefania Battistini; Fabio Giannini; Giuseppe Greco; Giuseppe Bibbò; Loreta Ferrera; Valeria Marini; Renzo Causarano; Michela Casula; Giuliana Lando; Maria Cristina Patrosso; Claudia Caponnetto; Paola Origone; Alessandro Marocchi; Alberto Del Corona; Gabriele Siciliano; Paola Carrera; Vincenzo Mascia; Marcello Giagheddu; Carlo Carcassi; Sandro Orrù; Cecilia Garrè; Silvana Penco
Journal:  J Neurol       Date:  2005-03-29       Impact factor: 4.849

Review 2.  Immature copper-zinc superoxide dismutase and familial amyotrophic lateral sclerosis.

Authors:  Sai V Seetharaman; Mercedes Prudencio; Celeste Karch; Stephen P Holloway; David R Borchelt; P John Hart
Journal:  Exp Biol Med (Maywood)       Date:  2009-07-13

Review 3.  Antisense therapy in neurology.

Authors:  Joshua J A Lee; Toshifumi Yokota
Journal:  J Pers Med       Date:  2013-08-02

4.  Rapid Progression of Sporadic ALS in a Patient Carrying SOD1 p.Gly13Arg Mutation.

Authors:  Myung-Jin Kim; Jae-Han Bae; Jeong-Min Kim; Hye Ryoun Kim; Byung-Nam Yoon; Jung-Joon Sung; Suk-Won Ahn
Journal:  Exp Neurobiol       Date:  2016-12-15       Impact factor: 3.261

5.  Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival.

Authors:  Qi Wang; Joshua L Johnson; Nathalie Y R Agar; Jeffrey N Agar
Journal:  PLoS Biol       Date:  2008-07-29       Impact factor: 8.029

6.  New application of intelligent agents in sporadic amyotrophic lateral sclerosis identifies unexpected specific genetic background.

Authors:  Silvana Penco; Massimo Buscema; Maria Cristina Patrosso; Alessandro Marocchi; Enzo Grossi
Journal:  BMC Bioinformatics       Date:  2008-05-30       Impact factor: 3.169

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.